TECH OUTLOOK 4APRIL - 2022Three C's to Enable Continuous Development and Manufacturing for Small Molecule Active Pharmaceutical IngredientIN MY OPINIONNick Thomson, Senior Director, Chemical Research & Development, Pfizer [NYSE:PFE]Aroga Biosciences, Inc.CL LaboratoryPg 34Pg 360812CUSTOMER-CENTRIC APPROACH TO CLINICAL RESEARCH SOLUTIONSPROPHARMA GROUPKevin Wysocki,PresidentManaging Impacts of Technology Transformations in PharmacovigilanceOlga Minkov, Executive Director, Operations ­ Pharmacovigilance & Epi., Gilead Sciences [NASDAQ:GILD]37TTECH OUTLOOKOP 102022CROs EMERGING
< Page 3 | Page 5 >